Skip to content
2000
Volume 14, Issue 10
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Tea catechins exhibit a broad range of pharmacological activities that impart beneficial effects on human health. Epigallocatechin-3-gallate (EGCG), one of the major tea catechins, has been widely associated with cancer prevention and treatment. In addition, tea catechins in combination with anticancer drugs are being evaluated as a new cancer treatment strategy. However, the interactions of anticancer drugs with tea catechins are largely unknown. Accumulated data indicate significant interactions between anticancer drugs and tea catechins, such as synergistic tumor inhibition or antagonist activity. Therefore, it is critical to understand comprehensively the effects of tea catechins on anticancer drugs. Focusing on evidence from preclinical studies, this paper will review the interactions between anticancer drugs and tea catechins, including pharmacodynamics and pharmacokinetics effects. We hope that by detailing the interactions between anticancer drugs and tea catechins, more attention will be directed to this important therapeutic combination in the future.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520614666140829123651
2014-12-01
2025-05-07
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520614666140829123651
Loading

  • Article Type:
    Research Article
Keyword(s): Drug interactions; EGCG; pharmacodynamics; pharmacokinetics; tea catechins
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test